This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Patkar, C. G.
Right arrow Articles by Kuhn, R. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patkar, C. G.
Right arrow Articles by Kuhn, R. J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, October 2009, p. 4103-4114, Vol. 53, No. 10
0066-4804/09/$08.00+0     doi:10.1128/AAC.00074-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Identification of Inhibitors of Yellow Fever Virus Replication Using a Replicon-Based High-Throughput Assay{triangledown}

Chinmay G. Patkar,1,{dagger} Martha Larsen,2 Michael Owston,1 Janet L. Smith,2 and Richard J. Kuhn1*

Markey Center for Structural Biology, Department of Biological Sciences, 915 W. State Street, Purdue University, West Lafayette, Indiana 47907-2054,1 Life Sciences Institute, University of Michigan, 210 Washtenaw Avenue, Ann Arbor, Michigan 48109-22162

Received 19 January 2009/ Returned for modification 20 February 2009/ Accepted 15 July 2009

Flaviviruses cause severe disease in humans and are a public health priority worldwide. However, no effective therapies or drugs are commercially available yet. Several flavivirus replicon-based assays amenable to high-throughput screening of inhibitors have been reported recently. We developed and performed a replicon-based high-throughput assay for screening small-molecule inhibitors of yellow fever virus (YFV) replication. This assay utilized packaged pseudoinfectious particles containing a YFV replicon that expresses Renilla luciferase in a replication-dependent manner. Several small-molecule compounds with inhibitory activity at micromolar concentrations were identified in the high-throughput screen. These compounds were subsequently tested for their inhibitory activities against YFV replication and propagation in low-throughput assays. Furthermore, YFV mutants that escaped inhibition by two of the compounds were isolated, and in both cases, the mutations were mapped to the NS4B coding region, suggesting a novel inhibitory target for these compounds. This study opens up new avenues for pursuing the nonenzymatic nonstructural proteins as targets for antivirals against YFV and other flaviviruses.

* Corresponding author. Mailing address: Markey Center for Structural Biology, Department of Biological Sciences, 915 W. State St., Purdue University, West Lafayette, IN 47907-2054. Phone: (765) 494-1164. Fax: (765) 496-1189. E-mail: kuhnr{at}purdue.edu

{triangledown} Published ahead of print on 3 August 2009.

{dagger} Present address: UMass Medical School, 55 Lake Avenue North, Worcester, MA 01655.

Antimicrobial Agents and Chemotherapy, October 2009, p. 4103-4114, Vol. 53, No. 10
0066-4804/09/$08.00+0     doi:10.1128/AAC.00074-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.





Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»